Health minister caps 2020 medicine price increases

Organisation: Position: Deadline Date: Location:

Prices of medicines and scheduled substances will only be adjusted by a maximum of 4.53% in 2020, health minister Zweli Mkhize announced in a recent notice published in the Government Gazette, reports Business Day.

Medicine prices in the private sector are tightly controlled by the health department, which usually permits one increase a year on the ceiling price for each drug, known as the single exit price. The report says the capped prices mean companies cannot pass on increased input costs to consumers, and thus face a squeeze on their profits.

Mkhize said in the notice applications for adjustments of the single exit price may be submitted for the first time from 10 January and no later than 28 February.

The report says the Pharmaceutical Task Group (PTG) welcomed Mkhize’s announcement. “The timeous announcement is an important element in ensuring sustainability of supply by manufacturers, as in previous years the notice has been somewhat delayed, which placed some strain on pharma businesses as they had to absorb inflationary increases whilst waiting for the adjustment to kick in,” PTG chair Stavros Nicolau said. “The timeous implementation is also important from a planning perspective and enables the pharma businesses and funders to better plan for the adjustment.”

Business Day report

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.